We are live on
!
Find out more
NAGE
Niagen Bioscience
NAGE
NAGE
143 hedge funds and large institutions have $162M invested in Niagen Bioscience in 2026 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 49 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
10% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 49
5.43% more ownership
Funds ownership: 40.37% → 45.8% (+5.4%)
15% less funds holding
Funds holding: 169 → 143 (-26)
21% less capital invested
Capital invested by funds: $205M → $162M (-$42.7M)
50% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 46
71% less call options, than puts
Call options by funds: $615K | Put options by funds: $2.09M
Holders
143
Holders Change
-26
Holders Change %
-15.38%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
54
Reduced
49
Closed
46
Calls
$615K
Puts
$2.09M
Net Calls
-$1.48M
Net Calls Change
+$370K
Top Buyers
Top Sellers
| 1 |
AG
Algert Global
San Francisco,
California
|
-$3.65M |
| 2 |
Morgan Stanley
New York
|
-$2.69M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.99M |
| 4 |
Jane Street
New York
|
-$1.93M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.54M |
